The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...
The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...
The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the ...
The company has had its ups -- the approval of its respiratory syncytial virus (RSV) vaccine back in 2024 -- and its downs -- the failure of its cytomegalovirus (CMV) vaccine candidate in a phase 3 ...
By Bhanvi Satija Feb 27 (Reuters) - Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on track to become the first single shot to ...
Straight Arrow News (English) on MSN
FDA to review Moderna's mRNA flu vaccine after initial rejection
Moderna announced that the FDA will review its new mRNA flu vaccine, a reversal less than two weeks after the agency refused ...
President Trump called Commissioner Marty Makary to the White House to discuss his frustration with the agency handling of ...
COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...
In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for ...
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
The FDA agreed to review Moderna’s experimental mRNA influenza vaccine after Moderna resubmitted its application with modifications.
Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results